BioVie Inc.
BIVI
$0.8408
$0.04766.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.53M | 2.07M | 2.68M | 1.97M | 2.25M |
| Depreciation & Amortization | 57.30K | 57.30K | 57.30K | 57.30K | 57.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.29M | 4.12M | 4.79M | 7.73M | 8.78M |
| Operating Income | -7.29M | -4.12M | -4.79M | -7.73M | -8.78M |
| Income Before Tax | -7.11M | -4.15M | -4.94M | -8.07M | -8.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.11M | -4.15M | -4.94M | -8.07M | -8.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.11M | -4.15M | -4.94M | -8.07M | -8.40M |
| EBIT | -7.29M | -4.12M | -4.79M | -7.73M | -8.78M |
| EBITDA | -7.24M | -4.06M | -4.73M | -7.67M | -8.72M |
| EPS Basic | -0.46 | -0.70 | -0.81 | -2.00 | -2.20 |
| Normalized Basic EPS | -0.28 | -0.41 | -0.51 | -1.13 | -1.38 |
| EPS Diluted | -0.46 | -0.70 | -0.83 | -2.00 | -2.20 |
| Normalized Diluted EPS | -0.28 | -0.41 | -0.51 | -1.13 | -1.38 |
| Average Basic Shares Outstanding | 15.72M | 6.40M | 6.11M | 4.48M | 3.82M |
| Average Diluted Shares Outstanding | 15.72M | 6.40M | 6.11M | 4.48M | 3.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |